--- title: Digital Science partners with Zhipu.AI to conduct data challenges and build COVID-19 information portal description: Digital Science has partnered with Beijing-based technology company Zhipu.Al to conduct data challenges and collaborate in building a COVID-19 information portal. image: https://news.lifesciencenewswire.com/hubfs/Imported_Blog_Media/digitalscience.jpg --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (34)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (20)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (15)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (244)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (9)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (108)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (283)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Drug Discovery & Development (147)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (55)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (132)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (6)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (25)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (86)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (114)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (4)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (5)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates - ##### SHARE - - - # [Digital Science partners with Zhipu.AI to conduct data challenges and build COVID-19 information portal](https://news.lifesciencenewswire.com/newsroom/covid-19/digital-science-partners-with-zhipu-ai-to-conduct-data-challenges-and-build-covid-19-information-portal) April 3, 2020 Digital Science, a leading technology company serving emergent needs across the research sector, is pleased to announce a partnership with Beijing-based technology company [Zhipu.AI](http://zhipu.ai/index.html) to conduct data challenges and collaborate in building a COVID-19 information portal. Zhipu.AI, a spin-out from Tsinghua University, aims to build an advanced artificial intelligence engine that can support and empower the research and innovation sectors globally. The company focuses on solving the current challenges of research organisations and government agencies, by using its extensive experience in analysing large-scale complex networks, deep semantic mining and leveraging innovative techniques with cognitive graphs. This strategic collaboration will see the two companies work together on a broad range of projects over the next several years. Some of the existing opportunities planned for the collaboration include joint hosting of a new set of data challenges centred around scholarly communications problems such as name disambiguation; and bringing together advanced analysis tools from both companies to create deeper insights for the sector. Collaboration will be a central theme of the new relationship and will see Digital Science's Overleaf ma de more seamlessly available to more Chinese users, enabling them to create, edit and publish their research   all from one browser using the real-time collaborative LaTeX editor. Professor Jie Tang, Chief Scientist at Zhipu, said: "Digital Science and Zhipu.AI are united by a common goal, that is, to leverage technology to improve information flows and encourage collaboration to facilitate research and innovation. "With our combined strengths in advanced digital technologies and insights into the scientific ecosystem from both a global and regional perspective, we are able to build more intelligent and reliable tools to encourage the exchange of ideas and improve research practices to better serve the needs of the research comm unity. We look forward to a fruitful partnership and are excited about our first joint initiatives on data challenges and the COVID-19 information portal." This partnership comes at a critical time with the global threat posed by COVID-19. Both teams will work together to ensure that both English and Chinese-language information is as widely shared as possible by providing a COVID-19 information portal with all related publications, datasets and clinical trials exported into a [google sheet](https://ds.digital-science.com/e/533712/X0ZQa232VWRmw-edit-usp-sharing/9jlmgf/904922646?h=6F3jjEW0Vd45CAejW6X-ZcSW1RaKkIpoxgIq89KXHAs) and hosted on Digital Science’s Figshare, as well as a dedicated [website](https://covid-19.aminer.cn/). The google sheet and website will be updated daily pulling all [relevant content on COVID-19](https://covid-19.dimensions.ai/) from Digital Science’s Dimensions platform, to make sharing and distributing this research information easier. Daniel Hook, CEO Digital Science, said: "It is a pleasure to be w   orking with colleagues from Zhipu.AI. Just as in academia itself, international collaborations between companies that support the emerging global research infrastructure are critical to establishing the tools and cultures that allow us to act globally to tackle the world’s hardest problems. We are proud to launch this initiative with our partners in China and look forward to sharing the fruits of this collaboration with colleagues, partners and clients around the world." Digital Science is a technology company working to make research more efficient. We invest in, nurture a   nd support innovative businesses and technologies that make all parts of the research process more open and effective. Our portfolio includes admired brands including Altmetric, CC Grant Tracker, Dimensions, Figshare, Gigantum, ReadCube, Symplectic, IFI Claims, GRID, Overleaf, Ripeta, Scismic and Writefull. We believe that together, we can help researchers make a difference. Visit [digital-science.com](https://www.digital-science.com/) and follow [@digitalsci](https://twitter.com/digitalsci) on Twitter. ![](https://news.lifesciencenewswire.com/hs-fs/hubfs/Imported_Blog_Media/digitalscience.jpg?width=326&height=215&name=digitalscience.jpg)   Categories: [Research](https://news.lifesciencenewswire.com/newsroom/tag/research), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) ##### Browse more news ## Recent releases #### [Enhanced Compliance Inc. (ECI) Appoints Taranjit S. Samra as Head of Medical Device Software Enginee...](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) July 6, 2026 Strengthens ECI’s AI & Digital Transformation capabilities to help clients develop the next generation of software-enabled medical technologies En... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomic...](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) #### [Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) June 16, 2026 Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)